Jushi Holdings (JUSHF) Receivables (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Receivables came in at $3.7 million in Q1 2026, up 165.46% year-on-year from $1.4 million in Q1 2025, and up 33.06% on a QoQ basis from $2.8 million in Q4 2025.
Jushi Holdings (JUSHF) Receivables (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Receivables data on file, last reported at $3.7 million in Q1 2026.
- On a quarterly basis, Receivables rose 165.46% year-over-year to $3.7 million in Q1 2026; TTM through Mar 2026 was $3.7 million, a 165.46% increase from a year earlier, with the FY2025 full-year figure at $2.8 million, up 91.72% from the prior year.
- Receivables for Q1 2026 stood at $3.7 million, up from $2.8 million in the prior quarter.
- Over the last five years, Receivables for JUSHF reached as high as $6.3 million in Q1 2023 and fell as low as $791000.0 in Q2 2025.
- Historically, Receivables has averaged $3.2 million across 5 years, with a median of $3.0 million in 2022.
- Across the five-year window, Receivables slumped 64.48% in 2025 and jumped 165.46% in 2026, its largest moves.
- Year by year, Receivables stood at $4.8 million in 2022, then dropped by 29.72% to $3.4 million in 2023, then tumbled by 56.78% to $1.5 million in 2024, then jumped by 91.72% to $2.8 million in 2025, then soared by 33.06% to $3.7 million in 2026.
- Per Business Quant data, the three most recent Receivables figures were $3.7 million in Q1 2026, $2.8 million in Q4 2025, and $872000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 2.99 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 6.46 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 312.00 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.29 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.58 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 768.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.15 Bn |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | 3.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.73 Mn |
| Dec 31, 2025 | 2.80 Mn |
| Sep 30, 2025 | 872,000.00 |
| Jun 30, 2025 | 791,000.00 |
| Mar 31, 2025 | 1.40 Mn |
| Dec 31, 2024 | 1.46 Mn |
| Sep 30, 2024 | 2.31 Mn |
| Jun 30, 2024 | 2.23 Mn |
| Mar 31, 2024 | 3.19 Mn |
| Dec 31, 2023 | 3.38 Mn |
| Sep 30, 2023 | 6.06 Mn |
| Jun 30, 2023 | 5.32 Mn |
| Mar 31, 2023 | 6.29 Mn |
| Dec 31, 2022 | 4.81 Mn |
| Sep 30, 2022 | 3.38 Mn |
| Jun 30, 2022 | 2.81 Mn |
| Dec 31, 2021 | 3.20 Mn |